Afuco™ Anti-Human IL20 ADCC Therapeutic Antibody, ADCC Enhanced
Anti-IL20 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The humanized antibodies specific to human interleukin 20 (IL-20) are used in treating diseases associated with the IL-20 signaling pathway, like osteoporosis, inflammatory disease (like rheumatoid arthritis), cancer, stroke, and renal failure.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-396CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | IL20 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store at -20°C for long-term storage. Store at 4°C for up to one month. Avoid freeze/thaw cycles. |